Skip to main content

Advertisement

Table 2 Propensity score logistic models of receiving at least one ASCT and of receiving consolidation phase treatment

From: Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma

  Receiving at least one ASCT Receiving consolidation phase treatment
  Coeff. S.E. P > |z| 95 % C.I. Coeff. S.E. P > |z| 95 % C.I.
Age > 50 years 0.2192 0.2005 0.2740 -0.1738 0.6122 -1.1036 0.3268 0.0010 -1.7442 -0.4631
Male sex -0.3034 0.1756 0.0840 -0.6476 0.0408 0.1046 0.1739 0.5470 -0.2361 0.4454
HB ≤ 10.5 g/dL -0.1751 0.1809 0.3330 -0.5296 0.1795 0.0556 0.1851 0.7640 -0.3072 0.4183
Plts ≤ 150 x109/L -0.1085 0.2592 0.6750 -0.6166 0.3995 0.3935 0.3059 0.1980 -0.2060 0.9930
Crea > 1.2 μmol/dL 0.0577 0.2220 0.7950 -0.3774 0.4927 0.0155 0.2167 0.9430 -0.4092 0.4402
LDH > 190 U/L 0.3097 0.2220 0.1630 -0.1254 0.7448 0.3123 0.2309 0.1760 -0.1403 0.7648
ISS > 1 0.2584 0.1864 0.1660 -0.1070 0.6238 0.1231 0.1770 0.4870 -0.2238 0.4700
IgA isotype 0.0031 0.2062 0.9880 -0.4011 0.4073 -0.1299 0.2136 0.5430 -0.5485 0.2887
Del(13q) 0.0375 0.1765 0.8320 -0.3086 0.3835 -0.0420 0.1722 0.8070 -0.3795 0.2954
T(4;14) -0.1485 0.2099 0.4790 -0.5599 0.2628 0.3715 0.2321 0.1100 -0.0835 0.8264
Del(17p) -0.2640 0.3039 0.3850 -0.8597 0.3317 0.4939 0.4040 0.2220 -0.2979 1.2858
Arm A 0.2628 0.1672 0.1160 -0.0649 0.5906 0.0036 0.1657 0.9830 -0.3212 0.3284
CR at induction      0.1073 0.2476 0.6650 -0.3781 0.5926
Constant 0.7531 0.2990 0.0120 0.1670 1.3392 1.3012 0.4762 0.0060 0.3678 2.2345